Steven Cohen’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.63M Buy
+223,907
New +$3.57M ﹤0.01% 2016
2025
Q1
– Sell
-849,621
Closed -$7.63M – 2033
2024
Q4
$7.63M Buy
+849,621
New +$6.93M 0.02% 796
2023
Q3
– Sell
-544,720
Closed -$5.27M – 2459
2023
Q2
$5.27M Sell
544,720
-1,395,253
-72% -$14.5M 0.02% 801
2023
Q1
$21.3M Sell
1,939,973
-243,173
-11% -$2.14M 0.07% 345
2022
Q4
$9.43M Buy
+2,183,146
New +$12.7M 0.03% 565
2021
Q2
– Sell
-314,565
Closed -$4.08M – 962
2021
Q1
$4.08M Sell
314,565
-1,824,896
-85% -$26.5M 0.02% 608
2020
Q4
$29.6M Sell
2,139,461
-204,290
-9% -$2.97M 0.14% 199
2020
Q3
$34.5M Sell
2,343,751
-1,499,990
-39% -$21.7M 0.18% 154
2020
Q2
$62.5M Sell
3,843,741
-825,602
-18% -$13.2M 0.41% 62
2020
Q1
$67.8M Buy
4,669,343
+1,073,710
+30% +$18.9M 0.55% 36
2019
Q4
$72.8M Buy
3,595,633
+3,573,880
+16,429% +$32.9M 0.38% 65
2019
Q3
$116K Sell
21,753
-330
-1% -$2K ﹤0.01% 969
2019
Q2
$145K Buy
22,083
+19,216
+670% +$122K ﹤0.01% 1004
2019
Q1
$19K Buy
+2,867
New +$19K ﹤0.01% 984
2018
Q1
– Sell
-537,000
Closed -$2.43M – 932
2017
Q4
$2.43M Buy
+537,000
New +$2.98M 0.01% 706

Other funds holding AUPH

Steven Cohen's AUPH Position: Q3 2026 in Review

Steven Cohen opened a new position in Aurinia Pharmaceuticals (AUPH) in Q3 2026: 223,907 shares worth $3.63M. The stake represents ﹤0.01% of the portfolio and ranks #2016 among its holdings. This is a return to the name: Steven Cohen previously reported a position in AUPH as recently as Q4 2024.

Steven Cohen first reported a position in AUPH in Q4 2017 and has held it in 15 quarters since. The position peaked at $72.8M in Q4 2019. 275 funds tracked by Wall St. Rank hold AUPH as of Q3 2026.

  • Steven Cohen held 223,907 shares of Aurinia Pharmaceuticals worth $3.63M as of Q3 2026.
  • Aurinia Pharmaceuticals was a new Steven Cohen position in Q3 2026.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #2016 holding.
  • Steven Cohen first reported a position in Aurinia Pharmaceuticals in Q4 2017 and has held it in 15 quarters since.
  • Steven Cohen's Aurinia Pharmaceuticals position peaked at $72.8M in Q4 2019.
  • 275 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.